Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × idelalisib × Lymphoid × Clear all

Phase

Status

Sponsor Class

INDUSTRY 32 OTHER 12 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 74 Vincristine 67 Doxorubicin 55 Prednisone 52 Cytarabine 48 Methotrexate 47 Rituximab 39 Etoposide 38 Radiotherapy 34 Dexamethasone 34 Filgrastim 33 Granulocyte Colony-Stimulating Factor 23 Mercaptopurine 22 Leucovorin 21 Daunorubicin 18 Calcium Dobesilate 18 pegaspargase 16 Asparaginase 15 merphos 14 Peripheral Blood Stem Cell Transplantation 14 Bleomycin 14 Thioguanine 13 Specimen Handling 12 Hydrocortisone 11 Gene Expression Profiling 11 fludarabine phosphate 10 Vinblastine 10 Methylprednisolone 10 Ifosfamide 10 Gemcitabine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03576443 2021-10-13

ILIAD

Nordic Lymphoma Group

Phase 2 Completed

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡